Skip to content

Clinical trials

Completed Leukemia, B-Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, B-Cell Status: Completed Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20063
20073
20082
20093
20107
20112
20126
20131
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)4
Pharmacyclics LLC.4
Memgen, LLC3
Celgene2
GlaxoSmithKline2
National Cancer Institute (NCI)2
Novartis Pharmaceuticals2
AbbVie1
AbbVie (prior sponsor, Abbott)1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, B-Cell31
Leukemia, Lymphocytic, Chronic, B-Cell21
Leukemia10
Lymphoma, B-Cell8
Lymphoma, Non-Hodgkin8
Leukemia, Lymphoid6
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Lymphoma, Mantle-Cell5
Burkitt Lymphoma4
Immune System Diseases4

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.